Patent details

EN | LT

LT - Iš normalių audinių gautos ksenogeninės vakcinos, skirtos pažeisti imuninės sistemos su navikais susijusių antigenų toleravimą

EN - XENOGENIC NORMAL TISSUE-DERIVED VACCINES FOR BREAKING THE IMMUNE TOLERANCE TO TUMOR-ASSOCIATED ANTIGENS

Legal status

Patent in force

Claims | Abstract | Licences/Sublicenses

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.: (2016.01)	A61K 39/00

Patent
(11)	Number of the document	6313
(13)	Kind of document	B
(21)	Application number	2014 112
(22)	Date of filing the application	2014-09-26
(41)	Date of publication of the application	2016-04-25
(45)	Date of publication of patent	2016-09-12

Applicant
(71)	UAB "INNOVITA RESEARCH", Laisvės pr. 125A, Vilnius, LT

Inventors
(72)	Victor I. SELEDTSOV, RU Galina V. SELEDTSOVA, RU Adas DARINSKAS, LT

Grantee
(73)	UAB "INNOVITA RESEARCH", Laisvės pr. 125A, Vilnius, LT

Attorney or representative
(74)	Otilija KLIMAITIENĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT

Title
(54)	XENOGENIC NORMAL TISSUE-DERIVED VACCINES FOR BREAKING THE IMMUNE TOLERANCE TO TUMOR-ASSOCIATED ANTIGENS

Last renewal fee
	Payment date	Validity (years)	Amount
	2025-09-26	12	289.00 EUR

Next renewal fee
	2026-09-26